您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > ErSO-DFP
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
ErSO-DFP
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
ErSO-DFP图片
CAS NO:2768139-76-8
包装与价格:
包装价格(元)
5mg电议
10mg电议

产品介绍
ErSO-DFP 是一种预期的未折叠蛋白反应 (a-UPR) 激活剂。ErSO-DFP 增强了对雌激素受体α+ (ERα+) 癌细胞的选择性,其选择性比 ErSO 更宽。ErSO-DFP 显示出抗肿瘤活性并导致小鼠模型中 MCF-7 肿瘤的显着消退。
Cas No.2768139-76-8
分子式C20H17F5N2O2
分子量412.35
储存条件Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

ErSO-DFP is an anticipatory unfolded protein response (a-UPR) activator. ErSO-DFP has enhanced selectivity for estrogen receptor alpha-positive (ERα+) cancer cells with a wider selectivity window than ErSO.ErSO-DFP displays antitumor activity and leads to profound regression of MCF-7 tumors in mice model[1].

[1]. Matthew W Boudreau, et al. Activators of the Anticipatory Unfolded Protein Response with Enhanced Selectivity for Estrogen Receptor Positive Breast Cancer. J Med Chem. 2022 Mar 10;65(5):3894-3912.